Study of hs-CRP Level in Prisoners in Mashhad and Their Relation to Demographic Factors

Document Type : Original Article

Authors

1 MD, specialist in Community Medicine, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 MD, Department of Community Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran

3 PHD, Immunology Research Center, Inflammation and Inflammatory Diseases division, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran

4 MSC, Immunology Research Center, Inflammation and Inflammatory Diseases division, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran

5 MD, Pathologist, Razavi Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran

Abstract

Background: Prisoners are a certain part of the population. Prisoners are kept in a closed environment for a long period of time and are prone to various diseases. Inflammatory biomarkers, including hs-CRP, are new risk factors for cardiovascular disease.

Objectives: The aim of this study was to compare hs-CRP levels in male and female prisoners and investigate the relationship between hs-CRP levels with related factors.

Methods: In this cross-sectional study, 316 prisoners in Mashhad Prison were investigated. A blood sample (7ml) was taken from each subject. Enzyme-linked immunosorbent assay (ELISA) technique was used to measure serum levels of highsensitivity C-reactive protein (hs-CRP). Descriptive statistics, chi-squared test, T-test, Pearson and Spearman’s correlation coefficients were used. P<0.05 was considered to be the level of significance.

Results: 316 prisoners were investigated of whom 211 (66.8%) were male and 105 (33.2%) were female. Mean hs-CRP level was 5.72±7.93 μg/ml in men and 7.48±8.39 in women. The difference between the two genders were statistically significant (p<0.001). The mean hs-CRP level was significantly higher in prisoners who did injection drug use compared to those who inhaled or consumed drugs (p<0.001). A significant correlation was observed between age, systolic blood pressure, frequency of imprisonment, height and BMI and hs-CRP levels.

Conclusion: Since hs-CRP is an important biomarker for non-communicable diseases, considering these factors and other risk factors for chronic diseases in the high-risk and vulnerable groups of prisoners, prevention and control measures can be planned by this group of people.

Keywords


Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1.Javadi A, Pourahmad M, Ataee B. Relation of frequency and duration of imprisonment with hepatitis B, C and HIV in prisoners. J Med Council Islam Repub Iran. 2006;385:64.
 
2. Rosen DL, Hammond WP, Wohl DA, Golin CE. Disease prevalence and use of health care among a national sample of black and white male state prisoners. J Health Care Poor Underserved. 2012;23(1):254-72. [PubMed: 22643475].
https://doi.org/10.1353/hpu.2012.0033
PMid:22643475 PMCid:PMC4047705
 
3. Iftene A, Manson A. Recent crime legislation and the challenge for prison health care. CMAJ. 2013;185(10):886-9. [PubMed: 23128279].
https://doi.org/10.1503/cmaj.120222
PMid:23128279 PMCid:PMC3707994
 
4. Manesh MJ, Soleimanifar P, Hosseini F. Personal, familial, social and economical characteristis of jailed addicted women. Iran J Nurs. 2005;17(40):47-54.
 
5. Jalilian F, Alavi J. Prevalence and pattern of drug abuse among prisoners in Kermanshah city. Health Educ Promot. 2013;1(2):41-8.
 
6. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald's heart disease: a textbook of cardiovascular medicine. New York: Elsevier Health Sciences; 2014.
 
7. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436-42. [PubMed: 9164317].
https://doi.org/10.1016/S0140-6736(96)07495-8
PMid:9164317
 
8. Kazemy T, Sharifzadeh G. Ten-year changes in mortality and risk factors in acute myocardial infarction in Birjand (1994- 2003). Horizon Med Sci. 2004;10(3):38-42.
 
9. McBride JD, Cooper MA. A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing. J Nanobiotechnol. 2008;6(1):5. [PubMed: 18445267].
https://doi.org/10.1186/1477-3155-6-5
PMid:18445267 PMCid:PMC2408609
 
10. Henderson DJ. Drug abuse and incarcerated women: a research review. J Subst Abuse Treat. 1998;15(6):579-87. [PubMed: 9845871].
https://doi.org/10.1016/S0740-5472(97)00319-X
PMid:9845871
 
11. O'Donovan A, Neylan TC, Metzler T, Cohen BE. Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain Behav Immun. 2012;26(4):642-9. [PubMed: 22366689].
https://doi.org/10.1016/j.bbi.2012.02.003
PMid:22366689 PMCid:PMC3322304
 
12. Kauffman RM, Ferketich AK, Murray DM, Bellair PE, Wewers ME. Tobacco use by male prisoners under an indoor smoking ban. Nicotine Tob Res. 2011;13(6):449-56. [PubMed: 21447838].
https://doi.org/10.1093/ntr/ntr024
PMid:21447838 PMCid:PMC3103718
 
13. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2): 181-91. [PubMed: 16445547].
https://doi.org/10.1111/j.1360-0443.2006.01316.x
PMid:16445547
 
14. Asgari S, Amini F, Naderi G, Roozbahani R. Relationship between opium addiction and cardiovascular risk factors. J Birjand Univ Med Sci. 2008;15(1):40-4.
 
15. Reece AS. High-sensitivity CRP in opiate addiction: relative and age-dependent elevations. Cardiovasc Toxicol. 2012;12(2):149- 57. [PubMed: 22297435].
https://doi.org/10.1007/s12012-012-9154-2
PMid:22297435
 
16. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138(11):891-7. [PubMed: 12779299].
https://doi.org/10.7326/0003-4819-138-11-200306030-00010
PMid:12779299
 
17. Ghazavi A, Solhi H, Moazzeni SM, Rafiei M, Mosayebi G. Cytokine profiles in long-term smokers of opium (Taryak). J Addict Med. 2013;7(3):200-3. [PubMed: 23519052].
https://doi.org/10.1097/ADM.0b013e31828baede
PMid:23519052
 
18. Ghazavi A, Mosayebi G, Solhi H, Rafiei M, Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunol Lett. 2013;153(1):22-6. [PubMed: 23850638].
https://doi.org/10.1016/j.imlet.2013.07.001
PMid:23850638
 
19. Ridker PM, Libby P. Risk factors for atherothrombotic disease. A textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005. P. 939-58.
 
20. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men. Eur Heart J. 2003;24(14):1365-72. [PubMed: 12871694].
https://doi.org/10.1016/S0195-668X(03)00260-4
PMid:12871694
 
21. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, et al. Lifetime smoking exposure affects the association of Creactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997;17(10):2167-76. [PubMed: 9351386].
https://doi.org/10.1161/01.ATV.17.10.2167
PMid:9351386
 
22. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens. 2001;19(5):857-61. [PubMed: 11393667].
https://doi.org/10.1097/00004872-200105000-00004
PMid:11393667
 
23. Kim KI, Lee JH, Chang HJ, Cho YS ,Youn TJ, Chung WY, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72(2):293-8. [PubMed: 18219169].
https://doi.org/10.1253/circj.72.293
PMid:18219169
 
24. Rawson ES, Freedson PS, Osganian SK, Matthews CE, Reed G, Ockene IS. Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc. 2003;35(7):1160-6. [PubMed: 12840637].
https://doi.org/10.1249/01.MSS.0000074565.79230.AB
PMid:12840637